as 05-09-2025 4:00pm EST
Founded: | 2015 | Country: | United States |
Employees: | N/A | City: | PITTSBURGH |
Market Cap: | N/A | IPO Year: | 2017 |
Target Price: | $218.63 | AVG Volume (30 days): | 344.7K |
Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 4.16 | EPS Growth: | 109.01 |
52 Week Low/High: | $133.22 - $219.34 | Next Earning Date: | 05-06-2025 |
Revenue: | $333,448,000 | Revenue Growth: | 247.53% |
Revenue Growth (this year): | 60.53% | Revenue Growth (next year): | 45.72% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Krishnan Krish S | KRYS | President and CEO | Mar 13 '25 | Sell | $177.74 | 50,000 | $8,889,524.59 | 1,556,956 | |
Krishnan Suma | KRYS | President, R&D | Mar 13 '25 | Sell | $177.74 | 50,000 | $8,889,524.59 | 1,533,056 | |
Romano Kathryn | KRYS | Chief Accounting Officer | Feb 26 '25 | Sell | $175.22 | 750 | $131,415.00 | 12,604 |
KRYS Breaking Stock News: Dive into KRYS Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Simply Wall St.
3 days ago
GuruFocus.com
3 days ago
Argus Research
3 days ago
Zacks
3 days ago
Zacks
4 days ago
MT Newswires
4 days ago
GlobeNewswire
4 days ago
The information presented on this page, "KRYS Krystal Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.